Almucantar Pty Ltd

Status: Registered
Australian Company Number: 167376669
Australian Business Number: 95167376669
Registration date: Monday 30th December 2013
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated


Almucantar Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2013-12-30 and was issued with the 167376669 ACN. Its Australian Business Number is 95167376669. Since 2014-09-25, the company is headquartered in SA, post code 5066. The previous headquarters were located in SA 5066 (from 2014-05-30 to 2014-09-25). Almucantar Pty Ltd was registered for the GST on 2014-05-31. The company has also used 1 business name, namely Coptercam Sa/nt from 2014-07-24 to 2016-12-30. The above data comes from the ABN database which was updated on 2016-12-30.


Details for ABN 95167376669

Type: Australian Private Company

ABN Status

Status From To
Active Monday 30th December 2013 current

Main Name

Name From To
Almucantar Pty Ltd Friday 30th May 2014 current

Business Names

Name From To
Coptercam Sa/nt Thursday 24th July 2014 Friday 30th December 2016

Main Location

Location From To
SA 5066 Thursday 25th September 2014 current
SA 5066 Friday 30th May 2014 Thursday 25th September 2014

Goods & Services Tax (GST)

Status From To
Registered Saturday 31st May 2014 current


Find company

SA 5066 Location

2018 © - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us:
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2018 (, and, ©Intellectual Property Government Open Data 2018, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.